How should I assess a male patient suspected of benign prostatic hyperplasia?

Assessment of Benign Prostatic Hyperplasia

All men with suspected BPH should undergo a structured evaluation that includes medical history with validated symptom questionnaires, physical examination with digital rectal exam, urinalysis, uroflowmetry, post-void residual measurement, and prostate imaging, with selective use of PSA testing and additional studies based on clinical findings. 1

Mandatory Initial Assessment

History and Symptom Evaluation

• Obtain a complete medical history focusing on LUTS severity, duration, and bother. 1
• Administer a validated symptom score questionnaire (International Prostate Symptom Score/IPSS) that includes quality of life assessment. 1 This is essential for both initial evaluation and monitoring treatment response.
• Use a bladder diary for at least 3 days if storage symptoms (urgency, frequency) or nocturia are prominent. 1 This objectively documents voiding patterns and fluid intake. 2

Physical Examination

• Perform digital rectal examination to assess prostate size, consistency, and nodularity. 1 This helps estimate prostate volume and detect suspicious findings requiring further cancer evaluation.
• Include neurological examination if neurogenic bladder is suspected. 1

Laboratory Testing

• Perform urinalysis (dipstick or microscopy) to exclude urinary tract infection, hematuria, or glucosuria. 1, 3 This is mandatory in all patients.
• Measure PSA if prostate cancer diagnosis would change management or if it assists in treatment decision-making. 1 PSA also helps estimate prostate size and predict progression risk. 1, 2 Counsel patients about PSA testing implications and the meaning of elevated results before testing. 1

Functional Assessment

• Perform uroflowmetry prior to any medical or invasive treatment. 1 While weak evidence supports it in initial assessment, it becomes strongly recommended before initiating therapy. 1
• Measure post-void residual urine volume. 1, 4 This identifies incomplete bladder emptying and risk of complications.

Imaging Studies

• Perform prostate imaging when considering surgical treatment (strong recommendation). 1 Prostate volume is critical for selecting appropriate interventional treatments and predicts symptom progression risk. 1
• Consider prostate imaging when selecting medical therapy, particularly to guide drug choice. 1 Transrectal ultrasound is preferred for accurate volume measurement, though transabdominal ultrasound is acceptable. 1
• Perform upper urinary tract ultrasound in men with large post-void residual, hematuria, or history of kidney stones. 1 This is a weak recommendation for routine use but becomes important with specific risk factors.

Selective/Optional Assessments

Renal Function

• Assess renal function (serum creatinine) if renal impairment is suspected based on history/examination, in the presence of hydronephrosis, or when considering surgical treatment. 1 This is not routinely required in uncomplicated cases. 2

Urethrocystoscopy

• Perform cystoscopy in men with hematuria history, urethral strictures, bladder cancer history, or when middle lobe presence would contraindicate specific interventions. 1 This should be done prior to minimally invasive/surgical therapies if findings would alter treatment selection. 1

Urodynamic Studies

• Reserve pressure-flow studies for complex cases where the relationship between LUTS and BPH is unclear. 1, 2 The UPSTREAM trial demonstrated that routine urodynamics in uncomplicated LUTS does not improve outcomes and should be used selectively. 1
• Consider urodynamics when detrusor underactivity or overactivity is suspected, or when previous treatments have failed. 1 Up to 61% of men with bladder outlet obstruction have detrusor overactivity, and 11-40% have detrusor underactivity. 1

Risk Stratification

Progression Risk Assessment

• Identify high-risk features for disease progression: prostate volume >30-40 mL, PSA elevation, severe symptoms (IPSS >19), large post-void residual, and older age. 1 These factors predict increased risk of acute urinary retention and need for surgery.
• Recognize that moderate-to-severe LUTS prevalence increases to nearly 50% by age 80, with acute urinary retention incidence rising to 34.7 episodes per 1,000 patient-years in men aged 70+. 1

Common Pitfalls to Avoid

• Do not skip validated symptom questionnaires – subjective history alone is insufficient for treatment planning and monitoring. 1
• Do not measure PSA without counseling – patients must understand implications of elevated results before testing. 1
• Do not perform routine urodynamics – reserve for complicated cases where diagnosis is uncertain. 1
• Do not overlook coexisting conditions – urinary tract infections, bladder cancer, neurogenic bladder, and urethral strictures can mimic or coexist with BPH. 4
• Alert ophthalmologists about alpha-blocker use – patients face increased risk of intraoperative floppy iris syndrome during cataract surgery. 1